Old Web
English
Sign In
Acemap
>
Paper
>
USE OF COMMERCIAL CLAIMS DATA TO ESTIMATE TRANSTHYRETIN-AMYLOID CARDIOMYOPATHY PREVALENCE AND INCIDENCE IN THE US
USE OF COMMERCIAL CLAIMS DATA TO ESTIMATE TRANSTHYRETIN-AMYLOID CARDIOMYOPATHY PREVALENCE AND INCIDENCE IN THE US
2021
Duncan Brown
Montserrat Vera-Llonch
José Tomás Ortiz Pérez
Sheila R. Reddy
Eunice Chang
Marian H. Tarbox
Jose Nativi-Nicolau
Nowell Fine
Keywords:
claims data
Transthyretin
Medicine
Amyloid cardiomyopathy
Incidence (epidemiology)
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]